MD

Pediatrix Medical Group, Inc. - 10-K Summary (Fiscal Year Ended Dec 31, 1998)

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended December 31, 1998, for Pediatrix Medical Group, Inc. (PMG). PMG is the nation's leading provider of physician management services to hospital-based Neonatal Intensive Care Units (NICUs), Pediatric Intensive Care Units (PICUs), and perinatal practices. As of year-end, the Company operated in 24 states and Puerto Rico, employing or contracting with approximately 350 physicians. The Company's strategy focuses on growth through acquisitions and same-unit volume increases, while managing the complexities of the managed care environment.

Key Financial Metrics

Operational Data: The Company managed 268,923 births and 27,911 NICU admissions in 1998. Administrative fees accounted for 5% of net patient service revenue.

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 43.9% to $185.4 million. Approximately 88.5% of this increase ($50.0 million) was driven by new units from acquisitions, while same-unit revenue grew 6.8% due to volume increases.
• Expense Increases: Salaries and benefits rose 39.6% to $113.7 million, primarily due to hiring physicians for new units. Depreciation and amortization increased 91.8% to $8.7 million, largely due to goodwill amortization from acquisitions.
• Liquidity Shift: Cash and cash equivalents dropped significantly from $18.6 million to $0.65 million. This decrease was primarily due to $88.9 million in cash used for 15 acquisitions during the year.
• Debt Utilization: The Company utilized its $75 million revolving credit facility, with $7.85 million outstanding at year-end, compared to no outstanding balance in 1997.
• Interest Income/Expense: The Company shifted from net interest income of $1.8 million in 1997 to net interest expense of $0.45 million in 1998 due to the drawdown of the credit facility and reduced investment income.

Guidance, Outlook, Risks, and Unusual Items

Outlook and Strategy: Management intends to continue growth through acquisitions and the development of regional networks to strengthen negotiating power with payors. The Company anticipates that funds from operations and the credit facility will be sufficient for working capital and acquisitions for the next 12 months.

Accounting Change: Effective January 1, 1999, the Company will expense incremental internal costs related to acquisitions as incurred, rather than capitalizing them. Had this policy been applied in 1998, net income would have been reduced by approximately $1.4 million.

Legal Proceedings: In February 1999, the Company and three principal officers were sued in federal court alleging violations of antifraud provisions regarding accounting practices and financial results. The Company believes the claims are without merit and intends to defend them vigorously.

Key Risks:

• Regulatory Environment: Approximately 22% of revenue is derived from government programs (Medicaid). Changes in reimbursement rates or regulations could materially impact results.
• Corporate Practice of Medicine: State laws prohibit corporations from practicing medicine. The Company utilizes Professional Association (PA) Contractors to comply, but faces risks of regulatory challenges regarding fee-splitting or corporate practice statutes.
• Acquisition Integration: Rapid growth and acquisitions carry risks of integration failure, diversion of management attention, and amortization of intangible assets.
• Year 2000 Compliance: The Company is testing critical systems for Y2K compliance, with costs expected not to exceed $500,000.

Investor Verification Checklist

• Cash Position: Verify the sustainability of operations with only $0.65 million in cash on hand and reliance on a $75 million credit line.
• Acquisition Accounting: Review the impact of the new accounting policy (expensing acquisition costs) on future earnings compared to the capitalized costs of 1998.
• Legal Exposure: Monitor the status of the February 1999 securities class action lawsuit regarding accounting practices.
• Payor Mix: Assess the risk associated with the 22% reliance on government reimbursement (Medicaid) and potential rate reductions.
• Goodwill Amortization: Evaluate the $8.7 million depreciation and amortization expense, which is heavily weighted toward goodwill from recent acquisitions.